Revance Therapeutics, Inc. (RVNC)
NASDAQ: RVNC · Real-Time Price · USD
3.090
+0.020 (0.65%)
At close: Dec 20, 2024, 4:00 PM
3.050
-0.040 (-1.29%)
After-hours: Dec 20, 2024, 4:47 PM EST
Revance Therapeutics Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Dec '24 Dec 20, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Market Capitalization | 324 | 772 | 1,519 | 1,172 | 1,886 | 821 | |
| Market Cap Growth | -46.07% | -49.18% | 29.62% | -37.87% | 129.62% | 10.32% | |
| Enterprise Value | 624 | 960 | 1,568 | 1,224 | 1,655 | 642 | |
| Last Close Price | 3.09 | 8.79 | 18.46 | 16.32 | 28.34 | 16.23 | |
| PS Ratio | 1.16 | 3.30 | 11.46 | 15.06 | 123.07 | 1988.80 | |
| PB Ratio | -3.34 | -5.09 | 120.54 | 17.11 | 5.04 | 3.64 | |
| P/TBV Ratio | - | - | - | - | 12.09 | 3.64 | |
| EV/Sales Ratio | 2.43 | 4.10 | 11.83 | 15.73 | 108.00 | 1555.54 | |
| Debt / Equity Ratio | -2.97 | -3.16 | 33.21 | 4.74 | 0.57 | 0.13 | |
| Asset Turnover | 0.52 | 0.44 | 0.24 | 0.12 | 0.03 | 0.00 | |
| Inventory Turnover | 2.33 | 4.76 | 10.74 | 17.43 | - | - | |
| Quick Ratio | 2.90 | 3.16 | 4.65 | 3.39 | 7.19 | 7.08 | |
| Current Ratio | 4.12 | 3.80 | 4.95 | 3.66 | 7.38 | 7.24 | |
| Return on Equity (ROE) | - | - | -879.28% | -127.07% | -94.06% | -85.92% | |
| Return on Assets (ROA) | -24.36% | -26.02% | -30.57% | -27.44% | -31.74% | -36.28% | |
| Return on Capital (ROIC) | -34.49% | -36.40% | -41.29% | -35.06% | -40.01% | -51.34% | |
| Earnings Yield | -56.90% | -41.97% | -23.47% | -24.01% | -14.96% | -19.41% | |
| FCF Yield | -60.13% | -28.95% | -12.96% | -19.79% | -9.68% | -13.32% | |
| Buyback Yield / Dilution | -16.69% | -16.35% | -7.71% | -16.37% | -33.47% | -20.15% | |
| Total Shareholder Return | -16.69% | -16.35% | -7.71% | -16.37% | -33.47% | -20.15% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.